79 related articles for article (PubMed ID: 17603924)
1. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Dalle-Donne I
Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
[No Abstract] [Full Text] [Related]
2. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
3. Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Estévez AG
Free Radic Biol Med; 2007 Jul; 43(2):163-4. PubMed ID: 17603926
[No Abstract] [Full Text] [Related]
4. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
[TBL] [Abstract][Full Text] [Related]
5. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
6. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
Chritin M; Savasta M; Besson G
Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathological study of patient with familial amyotrophic lateral sclerosis associated with a two-base pair deletion in the copper/zinc superoxide dismutase (SOD1) gene.
Kadekawa J; Fujimura H; Yanagihara T; Sakoda S
Acta Neuropathol; 2001 Apr; 101(4):415. PubMed ID: 11355314
[No Abstract] [Full Text] [Related]
8. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
9. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase.
Ferri A; Gabbianelli R; Casciati A; Paolucci E; Rotilio G; Carrì MT
J Neurochem; 2000 Aug; 75(2):606-13. PubMed ID: 10899935
[TBL] [Abstract][Full Text] [Related]
11. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
Gomes C; Keller S; Altevogt P; Costa J
Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways.
Allen S; Heath PR; Kirby J; Wharton SB; Cookson MR; Menzies FM; Banks RE; Shaw PJ
J Biol Chem; 2003 Feb; 278(8):6371-83. PubMed ID: 12475980
[TBL] [Abstract][Full Text] [Related]
15. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction.
Tiwari A; Hayward LJ
J Biol Chem; 2003 Feb; 278(8):5984-92. PubMed ID: 12458194
[TBL] [Abstract][Full Text] [Related]
16. A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Trieu VN; Liu R; Liu XP; Uckun FM
Biochem Biophys Res Commun; 2000 Jan; 267(1):22-5. PubMed ID: 10623568
[TBL] [Abstract][Full Text] [Related]
17. Neurochemistry of SOD1 and familial amyotrophic lateral sclerosis.
Carrì MT; Ceroni M; Ferri A; Gabbianelli R; Casciati A; Costa A
Funct Neurol; 2001; 16(1):73-82. PubMed ID: 11396274
[No Abstract] [Full Text] [Related]
18. [Amyotrophic lateral sclerosis and cognitive disorders: review and analysis of the literature].
Portet F; Touchon J; Camu W
Rev Neurol (Paris); 2001 Feb; 157(2):139-50. PubMed ID: 11283461
[TBL] [Abstract][Full Text] [Related]
19. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis.
Cozzolino M; Amori I; Pesaresi MG; Ferri A; Nencini M; Carrì MT
J Biol Chem; 2008 Jan; 283(2):866-74. PubMed ID: 18006498
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models].
Dupuis L; Muller A; Meininger V; Loeffler JP
Rev Neurol (Paris); 2004 Jan; 160(1):35-43. PubMed ID: 14978392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
